Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Compound 7p shows strong potential as an anticancer agent.

Pantethine may boost the immune system's ability to fight sarcoma.

Scalp cooling does not stop hair loss from radiotherapy.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Radiation damages salivary glands by harming blood vessels, but antioxidants might help protect them.

Cryotherapy and compression therapy might help prevent chemotherapy nerve damage, but more research is needed.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.